- recruitingPHASE1, PHASE2
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
This study looks at a new drug, AZD3470, alone or with other cancer medicines, for people with blood cancers like lymphoma. It aims to see if it's safe, how it works, and if it helps shrink the cancer. This is an early-stage trial.
United States · Australia · China - ongoing, recruitingHuman Pharmacology (Phase I)- Other
A study to learn about the study medicine called PF-08046032 in people with advanced cancers.
This study is looking into a new medicine, PF-08046032, for people with advanced cancers like certain lymphomas and solid tumours. It's an early-stage study to understand how the medicine works and if it's safe for people aged 18 and over.
Spain